Letter: risk of severe COVID-19 outcomes associated with inflammatory bowel disease medications-reassuring insights from the United Kingdom PREPARE-IBD multicentre cohort study.
Christopher Andrew LambShaji SebastianAlexandra J KentJonathan P SegalHaidee Aleman GonzalezMatthew James BrookesShameer J MehtaSreedhar SubramanianNeeraj BhalaLucy C HicksThomas Edward ConleyKamal V PatelGareth J WalkerNicholas Alexander Kennedynull nullPublished in: Alimentary pharmacology & therapeutics (2021)